Tag: Systemic sclerosis

Affecting an estimated 50 to 300 people per million, systemic sclerosis (SSc), also known as scleroderma, is a rare autoimmune disease that attacks the internal organs by causing an overproduction of collagen. This condition can lead to widespread scarring and thickening (fibrosis) that can severely impact organ function and quality of life.

Affecting hundreds of thousands of people in the U.S. alone, scleroderma is the disease where tissue hardens. This chronic autoimmune condition, derived from the Greek words for “hard” and “skin,” involves the overproduction of collagen, leading to a range of challenging symptoms.

Diagnosis codes are a crucial part of the medical billing and record-keeping system, but interpreting them can be complex due to different coding systems. For instance, the exact designation of code “7101” depends entirely on the context and the specific coding system being referenced, most commonly encountered as either a Veteran’s Affairs (VA) disability code for hypertension or an older, now-obsolete ICD-9 code for systemic sclerosis.

According to research, anemia affects a significant portion of individuals with systemic sclerosis, commonly known as scleroderma. The answer to **can scleroderma cause anemia?** is yes, and it is a known complication that can result from a number of factors, including the autoimmune disease's impact on various organ systems.

The term *sclerosis*, derived from the Greek word 'skleros' meaning 'hard,' refers to the pathological hardening or thickening of tissue within the body. While many people associate it with the neurological condition multiple sclerosis, the term describes a fundamental process that can affect numerous body parts, from the arteries to the skin.

Affecting more women than men, scleroderma is a rare autoimmune disease that can range from a mild skin condition to a serious systemic illness. The search term “What is scler o?” typically refers to scleroderma, a condition where the body produces too much collagen, leading to hardened skin and connective tissue.

Systemic sclerosis is a complex and often misunderstood condition, but understanding its fundamental nature is crucial for patients and their families. This article answers the question, "What type of disease is systemic sclerosis?" by exploring its autoimmune roots, its effects on the body's connective tissue, and the various ways it can manifest.

Fibrosis, the formation of excess fibrous connective tissue, affects over 5 million people worldwide and is the final stage of many chronic inflammatory diseases, often leading to progressive scarring and organ failure. Understanding the specific diseases associated with fibrosis is crucial for early detection and management.

Fibrosis accounts for up to 45% of all fatalities in the developed world, demonstrating its widespread and life-threatening impact. A process of excessive fibrous tissue accumulation, fibrosis can affect virtually any organ, leading to impaired function and potential failure.

According to the National Scleroderma Foundation, around 300,000 Americans have scleroderma, the disease that causes your body to harden. This autoimmune condition leads to the overproduction of collagen, resulting in fibrous, tight, and sometimes life-threatening tissue.